Science Explorer Interactive view Map
Company · Chicago · United States

Cell Biologics (United States)

Research works
99
▲ 32% vs 2013–17
Citations
1.3k
12.8 per fractional work
Top-10% rate
10.0%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: Cell Biologics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

What does Cell Biologics (United States) specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.1× the share of its output that it takes of world research.

  1. MedicineField · 22.3 works3.1×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.31× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.10× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 9.41× its world share, 4 worksImmunology and Micro…Neuroscience: 0.80× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.60× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 1.28× its world share, 0 worksChemical EngineeringChemistry: 1.45× its world share, 1 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEnergy: 0.24× its world share, 0 worksEnergyEngineering: 0.29× its world share, 2 worksEngineeringEnvironmental Science: 0.04× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.27× its world share, 0 worksMaterials ScienceHealth Professions: 0.11× its world share, 0 worksHealth ProfessionsMedicine: 3.12× its world share, 22 worksMedicineVeterinary: 1.32× its world share, 0 worksVeterinaryworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 9.4×. Every wedge is a field page.

Which keywords describe research at Cell Biologics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Monoclonal Antibodies, Glycosylation, Therapeutic Antibodies, Immunotherapy, Monoclonal Antibody, Antibody Engineering and Fc Receptors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Cancer Immunotherapy4▲ 78×2 topics
  2. Monoclonal Antibodies4▲ 127×3 topics
  3. Glycosylation4▲ 100×3 topics
  4. Therapeutic Antibodies4▲ 146×2 topics
  5. Immunotherapy3▲ 12×4 topics
  6. Monoclonal Antibody3▲ 157×2 topics
  7. Antibody Engineering3▲ 148×1 topic
  8. Fc Receptors3▲ 148×1 topic
  9. Tumor Regression3▲ 71×2 topics
  10. CAR T Cells3▲ 96×1 topic
  11. Chimeric Antigen Receptor3▲ 96×1 topic
  12. Inflammation2▲ 3.1×15 topics
  13. Innate Immunity2▲ 19×5 topics
  14. Antigen Presentation2▲ 69×2 topics
  15. Breast Cancer2▲ 25×2 topics
  16. PET Imaging2▲ 35×2 topics
  17. HER22▲ 200×1 topic
  18. Immunity2▲ 14×5 topics
  19. Trastuzumab2▲ 126×1 topic
  20. Cancer Treatment2▲ 24×2 topics
  21. Targeted Therapy2▲ 24×2 topics
  22. Radioimmunotherapy2▲ 182×1 topic
  23. Radiopharmaceuticals2▲ 182×1 topic
  24. Dendritic Cells2▲ 54×1 topic
  25. Epidemiology2▲ 1.20×15 topics
  26. Tumor Antigen2▲ 79×1 topic
  27. Tumor Microenvironment2▲ 9.7×3 topics
  28. Angiogenesis2▲ 13×5 topics
  29. Oxidative Stress1▲ 2.3×7 topics
  30. Biopharmaceuticals1▲ 64×2 topics
  31. Immune Checkpoint Blockade1▲ 28×1 topic
  32. Immunogenicity1▲ 76×2 topics
  33. PD-1 and PD-L11▲ 28×1 topic
  34. Cell Culture1▲ 26×2 topics
  35. Prevention1▲ 6.8×3 topics
  36. Public Health1▲ 1.98×3 topics
  37. Nanoparticles1▲ 2.2×4 topics

Which research topics does Cell Biologics (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, HER2/EGFR in Cancer Research and Radiopharmaceutical Chemistry and Applications.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  2. 2 CAR-T cell therapy research Oncology 3 works
  3. 3 HER2/EGFR in Cancer Research Oncology 2 works
  4. 4 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
  5. 5 Immunotherapy and Immune Responses Immunology 2 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  8. 8 Protein purification and stability Molecular Biology 1 works
  9. 9 Liver physiology and pathology Hepatology 1 works
  10. 10 Cancer Cells and Metastasis Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.5%not open60.5%

World: 28% of research is openly available.

with international co-authors37.5%domestic only62.5%

World: 19% is written across borders.

How has Cell Biologics (United States)'s research output changed?

Output in 2018–2022 was 32% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Chicago

All research institutions in Chicago

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.